Image: Government ExecutiveThe FDA requires follow-up studies for drugs and devices. Years later, many still aren’t done - Government Executive
• An analysis of FDA data revealed that hundreds of required postmarket studies for drugs and medical devices are running behind schedule. • The findings indicate that many manufacturers have failed to complete follow-up research mandated by the agency years after product approval. • These delays hinder the FDA's ability to monitor long-term safety and effectiveness, potentially leaving patients at risk from undetected side effects.
govexec.com

